US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Medicines

84.90

0.0000

Volume:- -

Turnover:- -

Market Cap:6.79B

PE:-27.06

High:84.90

Open:84.90

Low:84.90

Close:84.90

52wk High:84.98

52wk Low:23.15

Shares:79.95M

Float Shares:74.86M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.1374

EPS(LYR):-1.6740

ROE:553.30%

ROA:-13.71%

PB:178.02

PE(LYR):-50.72

Loading ...

Overview Company News Filings

BeOne Medicines Grants New RSUs to 188 Employees Under Incentive Plan

CICC Sticks to Their Buy Rating for BeOne Medicines Ltd (6160)

BeOne Medicines Pharma Alliances Contrast With High P/E And Valuation Upside

Simply Wall St.

TYK Medicines Completes Full H-Share Conversion to Boost Market Liquidity

Assessing BeOne Medicines (NasdaqGS:ONC) Valuation After Its Recent Rebrand And Share Price Weakness

Simply Wall St.

Guotai Haitong Sticks to Their Buy Rating for BeOne Medicines Ltd (6160)

BeOne Medicines Is Maintained at Overweight by Barclays

BeOne Medicines Gains Clean Swiss Audit in Voluntary Disclosure

RBC Lifts Price Target on BeOne Medicines to $425 From $417, Keeps Outperform Rating

MT Newswires Live

Vanda Pharmaceuticals Receives Negative Opinion From European Medicines Agency's CHMP for Iloperidone

MT Newswires Live

Guggenheim Keeps Their Buy Rating on BeOne Medicines (ONC)

BeOne Medicines (ONC) Receives a Buy from RBC Capital

BeOne Medicines Ltd (6160) Receives a Buy from DBS

BeOne Medicines Returns to Profit in 2025 on 40% Revenue Jump

MT Newswires Live

Analysts Conflicted on These Healthcare Names: Ramsay Health Care (OtherRMSYF) and BeOne Medicines (ONC)

BeOne Medicines Files 2025 Form 10-K, Underscoring Cross-Border Compliance

BeOne Medicines posts 2025 results and issues cautious 2026 outlook

BeOne Medicines Q4 Adjusted Earnings, Revenue Rise

MT Newswires Live

BeOne Medicines sees 2026 revenue $6.2B-$6.4B, consensus $6.44B

GUIDANCE: (ONC) BeOne Medicines Expects 2026 Revenue Range $6.2B to $6.4B, vs. FactSet Est of $6.41B

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/MDCO/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MDCO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MDCO\",,,,,undefined,":{"symbol":"MDCO","market":"US","secType":"STK","nameCN":"Medicines","latestPrice":84.9,"timestamp":1578085200000,"preClose":84.9,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":74862655,"shares":79948329,"eps":-3.137449,"marketStatus":"Halted","change":0,"latestTime":"04-06 07:28:08 EDT","open":84.9,"high":84.9,"low":84.9,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.137449,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1775482200000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":965707200000,"exchange":"NASDAQ","adjPreClose":84.9,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MDCO\",,,,,undefined,":{"symbol":"MDCO","floatShares":74862655,"roa":"-13.71%","roe":"553.30%","lyrEps":-1.673974,"shares":79948329,"dividePrice":0,"high":84.9,"amplitude":0,"preClose":84.9,"low":84.9,"week52Low":23.15,"pbRate":"178.02","week52High":84.98,"institutionHeld":1.2829,"latestPrice":84.9,"eps":-3.137449,"divideRate":0,"volume":0,"delay":0,"ttmEps":-3.137449,"open":84.9,"prevYearClose":84.94},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MDCO\",params:#limit:5,,,undefined,":[{"date":"2019-10-30","symbol":"MDCO","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2019/09","expectedEps":-0.84,"defaultRemindTime":1572422400000,"name":null,"time":"Pre-Market","dateTimestamp":1572408000000,"actualEps":null},{"date":"2019-07-24","symbol":"MDCO","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2019/06","expectedEps":-0.66,"defaultRemindTime":1563955200000,"name":null,"time":"Pre-Market","dateTimestamp":1563940800000,"actualEps":-0.67},{"market":"US","date":"2019-04-25","symbol":"MDCO","fiscalQuarterEnding":"2019/03","expectedEps":-0.71,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1556164800000,"reportTimeType":"pre","actualEps":-0.68},{"market":"US","date":"2019-02-27","symbol":"MDCO","fiscalQuarterEnding":"2018/12","expectedEps":-0.35,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1551243600000,"reportTimeType":"pre","actualEps":-0.67},{"market":"US","date":"2018-11-08","symbol":"MDCO","fiscalQuarterEnding":"2018/09","expectedEps":-0.48,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1541653200000,"reportTimeType":"pre","actualEps":-0.7}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MDCO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MDCO\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MDCO\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2617068605","title":"BeOne Medicines Grants New RSUs to 188 Employees Under Incentive Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2617068605","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617068605?lang=en_us&edition=fundamental","pubTime":"2026-03-06 17:39","pubTimestamp":1772789970,"startTime":"0","endTime":"0","summary":"BeOne Medicines Ltd ( ($HK:6160) ) has shared an update. BeOne Medicines has granted 21,197 restricted share units in the form of ADSs, representin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/beone-medicines-grants-new-rsus-to-188-employees-under-incentive-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/beone-medicines-grants-new-rsus-to-188-employees-under-incentive-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617508952","title":"CICC Sticks to Their Buy Rating for BeOne Medicines Ltd (6160)","url":"https://stock-news.laohu8.com/highlight/detail?id=2617508952","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617508952?lang=en_us&edition=fundamental","pubTime":"2026-03-06 08:26","pubTimestamp":1772756761,"startTime":"0","endTime":"0","summary":"In a report released on March 4, from CICC maintained a Buy rating on BeOne Medicines Ltd, with a price target of HK$250.00. The company’s shares c...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/cicc-sticks-to-their-buy-rating-for-beone-medicines-ltd-6160-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/cicc-sticks-to-their-buy-rating-for-beone-medicines-ltd-6160-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CICC","MDCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617550807","title":"BeOne Medicines Pharma Alliances Contrast With High P/E And Valuation Upside","url":"https://stock-news.laohu8.com/highlight/detail?id=2617550807","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617550807?lang=en_us&edition=fundamental","pubTime":"2026-03-05 00:30","pubTimestamp":1772641827,"startTime":"0","endTime":"0","summary":"BeOne Medicines, listed as NasdaqGS:ONC, announced new collaborations with Amgen, Bristol Myers Squibb, and Novartis.\nThe partnerships are focused on advancing BeOne Medicines' oncology therapy pipeline alongside its existing commercial products.\nThe company also highlighted ongoing clinical trials that sit alongside these new pharma alliances.\n\nBeOne Medicines operates in oncology, an area where large pharma groups and smaller specialists often work together to bring new treatments through...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-onc/beone-medicines/news/beone-medicines-pharma-alliances-contrast-with-high-pe-and-v","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-onc/beone-medicines/news/beone-medicines-pharma-alliances-contrast-with-high-pe-and-v","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","MDCO","BK4526","BK4139","ONC","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616334245","title":"TYK Medicines Completes Full H-Share Conversion to Boost Market Liquidity","url":"https://stock-news.laohu8.com/highlight/detail?id=2616334245","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616334245?lang=en_us&edition=fundamental","pubTime":"2026-03-04 17:17","pubTimestamp":1772615859,"startTime":"0","endTime":"0","summary":"The latest update is out from TYK Medicines, Inc. Class H ( ($HK:2410) ). TYK Medicines, Inc. has completed the conversion of 4,608,000 unlisted sh...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tyk-medicines-completes-full-h-share-conversion-to-boost-market-liquidity?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tyk-medicines-completes-full-h-share-conversion-to-boost-market-liquidity?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616329697","title":"Assessing BeOne Medicines (NasdaqGS:ONC) Valuation After Its Recent Rebrand And Share Price Weakness","url":"https://stock-news.laohu8.com/highlight/detail?id=2616329697","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616329697?lang=en_us&edition=fundamental","pubTime":"2026-03-03 22:23","pubTimestamp":1772547790,"startTime":"0","endTime":"0","summary":"BeOne Medicines (ONC) has drawn investor attention after its rebrand from BeiGene, Ltd. to BeOne Medicines AG in May 2025. The change highlights a broad oncology portfolio across commercial, clinical, and preclinical cancer therapies.\nSee our latest analysis for BeOne Medicines.\nAfter the rebrand, BeOne Medicines’ share price has been under pressure in the short term, with a 7 day share price return of a 15.18% decline and a 30 day share price return of a 7.64% decline. Its 1 year total...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-onc/beone-medicines/news/assessing-beone-medicines-nasdaqgsonc-valuation-after-its-re","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-onc/beone-medicines/news/assessing-beone-medicines-nasdaqgsonc-valuation-after-its-re","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4526","ONC","BK4139","BK4588","MDCO","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614817553","title":"Guotai Haitong Sticks to Their Buy Rating for BeOne Medicines Ltd (6160)","url":"https://stock-news.laohu8.com/highlight/detail?id=2614817553","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614817553?lang=en_us&edition=fundamental","pubTime":"2026-02-28 22:26","pubTimestamp":1772288813,"startTime":"0","endTime":"0","summary":"In a report released yesterday, from Guotai Haitong maintained a Buy rating on BeOne Medicines Ltd, with a price target of HK$212.09. The company’s...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/guotai-haitong-sticks-to-their-buy-rating-for-beone-medicines-ltd-6160-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/guotai-haitong-sticks-to-their-buy-rating-for-beone-medicines-ltd-6160-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614385773","title":"BeOne Medicines Is Maintained at Overweight by Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2614385773","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614385773?lang=en_us&edition=fundamental","pubTime":"2026-02-27 23:17","pubTimestamp":1772205420,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ONC/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 27, 2026 10:17 ET (15:17 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614625851","title":"BeOne Medicines Gains Clean Swiss Audit in Voluntary Disclosure","url":"https://stock-news.laohu8.com/highlight/detail?id=2614625851","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614625851?lang=en_us&edition=fundamental","pubTime":"2026-02-27 21:54","pubTimestamp":1772200449,"startTime":"0","endTime":"0","summary":"The latest update is out from BeOne Medicines Ltd ( ($HK:6160) ). BeOne Medicines Ltd., a Swiss-incorporated biopharmaceutical company listed in Ho...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/beone-medicines-gains-clean-swiss-audit-in-voluntary-disclosure?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/beone-medicines-gains-clean-swiss-audit-in-voluntary-disclosure?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614885652","title":"RBC Lifts Price Target on BeOne Medicines to $425 From $417, Keeps Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2614885652","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614885652?lang=en_us&edition=fundamental","pubTime":"2026-02-27 21:08","pubTimestamp":1772197713,"startTime":"0","endTime":"0","summary":"BeOne Medicines (ONC) has an average rating of buy and mean price target of $413.72, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ban","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MDCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614378855","title":"Vanda Pharmaceuticals Receives Negative Opinion From European Medicines Agency's CHMP for Iloperidone","url":"https://stock-news.laohu8.com/highlight/detail?id=2614378855","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614378855?lang=en_us&edition=fundamental","pubTime":"2026-02-27 20:52","pubTimestamp":1772196745,"startTime":"0","endTime":"0","summary":"Vanda Pharmaceuticals  has received a negative opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use regarding iloperidone for the treatment of schizophrenia and the acute treatment of manic or mixed episodes associated with bipolar disorder, the regulator said Friday.The EMA recommended the refusal of marketing authorization for iloperidone and said Vanda may apply for a re-examination of the opinion within 15 days.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","VNDA","MDCO","BK4087","CHMP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614585373","title":"Guggenheim Keeps Their Buy Rating on BeOne Medicines (ONC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2614585373","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614585373?lang=en_us&edition=fundamental","pubTime":"2026-02-27 20:38","pubTimestamp":1772195903,"startTime":"0","endTime":"0","summary":"Guggenheim analyst maintained a Buy rating on BeOne Medicines yesterday and set a price target of $410.00. The company’s shares closed yesterday at...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/guggenheim-keeps-their-buy-rating-on-beone-medicines-onc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/guggenheim-keeps-their-buy-rating-on-beone-medicines-onc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDCO","ONC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614685385","title":"BeOne Medicines (ONC) Receives a Buy from RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2614685385","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614685385?lang=en_us&edition=fundamental","pubTime":"2026-02-27 20:18","pubTimestamp":1772194738,"startTime":"0","endTime":"0","summary":"RBC Capital analyst Leonid Timashev maintained a Buy rating on BeOne Medicines yesterday and set a price target of $425.00. The company’s shares cl...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/beone-medicines-onc-receives-a-buy-from-rbc-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/beone-medicines-onc-receives-a-buy-from-rbc-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4139","LU0029864427.USD","ONC","LU0310800379.SGD","LU0128525929.USD","LU0708994859.HKD","MDCO","LU1267930573.SGD","BK4588","BK4207","BK4526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614880366","title":"BeOne Medicines Ltd (6160) Receives a Buy from DBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2614880366","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614880366?lang=en_us&edition=fundamental","pubTime":"2026-02-27 16:05","pubTimestamp":1772179543,"startTime":"0","endTime":"0","summary":"DBS analyst Mark Kong CFA maintained a Buy rating on BeOne Medicines Ltd today and set a price target of HK$290.00. According to TipRanks, Kong CFA...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/beone-medicines-ltd-6160-receives-a-buy-from-dbs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/beone-medicines-ltd-6160-receives-a-buy-from-dbs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DBS","MDCO","CFA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614018210","title":"BeOne Medicines Returns to Profit in 2025 on 40% Revenue Jump","url":"https://stock-news.laohu8.com/highlight/detail?id=2614018210","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614018210?lang=en_us&edition=fundamental","pubTime":"2026-02-27 10:00","pubTimestamp":1772157644,"startTime":"0","endTime":"0","summary":"BeOne Medicines  posted 2025 attributable net profit of 1.42 billion yuan, compared with a loss of 4.98 billion yuan the previous year.Basic earnings per share stood at 1.00 yuan, versus a loss per share of 3.64 yuan, according to a Friday filing with the Shanghai bourse.The biopharmaceutical company's operating revenue rose 40% year over year to 38.2 billion yuan from 27.2 billion yuan.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MDCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614070505","title":"Analysts Conflicted on These Healthcare Names: Ramsay Health Care (OtherRMSYF) and BeOne Medicines (ONC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2614070505","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614070505?lang=en_us&edition=fundamental","pubTime":"2026-02-27 07:10","pubTimestamp":1772147408,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Ramsay Health Care (RMSYF – Research Report) and BeOne Medicines ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-ramsay-health-care-otherrmsyf-and-beone-medicines-onc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-ramsay-health-care-otherrmsyf-and-beone-medicines-onc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","HCSG","LU0029874061.USD","BK4585","BK4137","BK4588","MDCO","BK4526","LABU","LU0128526141.USD","ONC","XLV","BK4581","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614044310","title":"BeOne Medicines Files 2025 Form 10-K, Underscoring Cross-Border Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2614044310","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614044310?lang=en_us&edition=fundamental","pubTime":"2026-02-26 20:53","pubTimestamp":1772110385,"startTime":"0","endTime":"0","summary":"BeOne Medicines Ltd ( ($HK:6160) ) just unveiled an announcement. BeOne Medicines Ltd has announced that it has filed its annual report on Form 10-...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/beone-medicines-files-2025-form-10-k-underscoring-cross-border-compliance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/beone-medicines-files-2025-form-10-k-underscoring-cross-border-compliance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614045969","title":"BeOne Medicines posts 2025 results and issues cautious 2026 outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2614045969","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614045969?lang=en_us&edition=fundamental","pubTime":"2026-02-26 19:55","pubTimestamp":1772106934,"startTime":"0","endTime":"0","summary":"An update from BeOne Medicines Ltd ( ($HK:6160) ) is now available. BeOne Medicines Ltd., a Switzerland-based biopharmaceutical group listed in Hon...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/beone-medicines-posts-2025-results-and-issues-cautious-2026-outlook?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/beone-medicines-posts-2025-results-and-issues-cautious-2026-outlook?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614438690","title":"BeOne Medicines Q4 Adjusted Earnings, Revenue Rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2614438690","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614438690?lang=en_us&edition=fundamental","pubTime":"2026-02-26 19:36","pubTimestamp":1772105792,"startTime":"0","endTime":"0","summary":"BeOne Medicines  reported Q4 adjusted diluted earnings Thursday of $1.95 per share, up from $0.15 a year earlier.A single analyst polled by FactSet expected $0.95.Total revenue for the quarter ended Dec. 31 was $1.50 billion, up from $1.13 billion a year earlier.Analysts polled by FactSet expected $1.47 billion.BeOne said it expects 2026 total revenue of $6.2 billion to $6.4 billion. Analysts polled by FactSet expect $6.4 billion.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MDCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614043640","title":"BeOne Medicines sees 2026 revenue $6.2B-$6.4B, consensus $6.44B","url":"https://stock-news.laohu8.com/highlight/detail?id=2614043640","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614043640?lang=en_us&edition=fundamental","pubTime":"2026-02-26 19:34","pubTimestamp":1772105672,"startTime":"0","endTime":"0","summary":"Sees 2026 non-GAAP operating income $1.4B-$1.5B. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial ne...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/beone-medicines-sees-2026-revenue-6-2b-6-4b-consensus-6-44b-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/beone-medicines-sees-2026-revenue-6-2b-6-4b-consensus-6-44b-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614010580","title":"GUIDANCE: (ONC) BeOne Medicines Expects 2026 Revenue Range $6.2B to $6.4B, vs. FactSet Est of $6.41B","url":"https://stock-news.laohu8.com/highlight/detail?id=2614010580","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614010580?lang=en_us&edition=fundamental","pubTime":"2026-02-26 19:05","pubTimestamp":1772103937,"startTime":"0","endTime":"0","summary":"GUIDANCE: (ONC) BeOne Medicines Expects 2026 Revenue Range $6.2B to $6.4B, vs. FactSet Est of $6.41B","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ONC","MDCO"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":199,"code":"91000000","status":"200"}]}}